论文信息 - Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. - 字舞流文

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

J. Blay | M. van Glabbeke | J. Verweij | A. Le Cesne | M. Schlemmer | P. Casali | J. Zalcberg | I. Judson | P. Reichardt | Michelle Brown | M. V. Van Glabbeke